title: Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
authors.affiliation: Thomas Jefferson University, Philadelphia, PA, USA. daniel.brown@jefferson.edu
authors.forename: Daniel B
authors.initials: DB
authors.lastname: Brown
authors.forename: Boris
authors.initials: B
authors.lastname: Nikolic
authors.forename: Anne M
authors.initials: AM
authors.lastname: Covey
authors.forename: Charles W
authors.initials: CW
authors.lastname: Nutting
authors.forename: Wael E A
authors.initials: WE
authors.lastname: Saad
authors.forename: Riad
authors.initials: R
authors.lastname: Salem
authors.forename: Constantinos T
authors.initials: CT
authors.lastname: Sofocleous
authors.forename: Daniel Y
authors.initials: DY
authors.lastname: Sze
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016461:Chemoembolization, Therapeutic / Q000009:adverse effects / Q000592:standards*; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000592:standards*; D019317:Evidence-Based Medicine / Q000592:standards; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000098:blood supply / Q000188:drug therapy / Q000628:therapy*; D018579:Patient Selection; D058996:Quality Improvement / Q000592:standards*; D018570:Risk Assessment
chemical_list: D000970:Antineoplastic Agents